Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Zinganell

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Journal of Neural Transmission (Vienna, Austria : 1996)|July 28, 2025
Silent destruction: hidden muscle wasting and body decline in early Huntington's diseaseMarina Peball, Pia Schörghuber, Federico Carbone, et al.
Multiple Sclerosis and Related Disorders|April 27, 2025
Clinical characteristics and outcome of double-AQP4/MOG-seronegative and not MS-associated monophasic and relapsing demyelinating transverse myelitis: A monocenter studyMichael Auer, Harald Hegen, Franziska Di Pauli, et al.
Scientific Reports|December 3, 2021
Experiences in treatment of multiple sclerosis with natalizumab from a real-life cohort over 15 yearsMichael Auer, Anne Zinganell, Harald Hegen, et al.
European Journal of Neurology|February 14, 2023
Immunization status in patients with multiple sclerosis: A cross-sectional, monocenter study in AustriaKlaus Berek, Philipp Deisl, Maximilian Bichler, et al.
Multiple Sclerosis and Related Disorders|January 3, 2020
To treat or not to treat: Sequential individualized treatment evaluation in relapsing multiple sclerosisGabriel Bsteh, Harald Hegen, Carolin Dosser, et al.
Journal of Central Nervous System Disease|April 4, 2022
Recovery of Chronic Inflammatory Demyelinating Polyneuropathy on Treatment With Ocrelizumab in a Patient With Co-Existing Multiple SclerosisMichael Auer, Harald Hegen, Anna Hotter, et al.
Plos One|June 12, 2020
Influence of physical activity on serum vitamin D levels in people with multiple sclerosisAngelika Bauer, Ivan Lechner, Michael Auer, et al.
European Journal of Neurology|October 19, 2020
Cerebrospinal fluid protein in Guillain-Barré syndrome: Need for age-dependent interpretationHarald Hegen, Felix Ladstätter, Gabriel Bsteh, et al.
Multiple Sclerosis and Related Disorders|April 27, 2022
Alemtuzumab induced hemodynamic change in relapsing multiple sclerosis occurs independent of corticosteroid premedication - a retrospective multicentre studyFranziska Di Pauli, Katharina Riedl, Harald Hegen, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|September 14, 2020
Inner nuclear layer and olfactory threshold are interlinked and reflect inflammatory activity in multiple sclerosisGabriel Bsteh, Harald Hegen, Patrick Altmann, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Journal of Neural Transmission (Vienna, Austria : 1996)|July 28, 2025
Silent destruction: hidden muscle wasting and body decline in early Huntington's diseaseMarina Peball, Pia Schörghuber, Federico Carbone, et al.
Multiple Sclerosis and Related Disorders|April 27, 2025
Clinical characteristics and outcome of double-AQP4/MOG-seronegative and not MS-associated monophasic and relapsing demyelinating transverse myelitis: A monocenter studyMichael Auer, Harald Hegen, Franziska Di Pauli, et al.
Scientific Reports|December 3, 2021
Experiences in treatment of multiple sclerosis with natalizumab from a real-life cohort over 15 yearsMichael Auer, Anne Zinganell, Harald Hegen, et al.
European Journal of Neurology|February 14, 2023
Immunization status in patients with multiple sclerosis: A cross-sectional, monocenter study in AustriaKlaus Berek, Philipp Deisl, Maximilian Bichler, et al.
Multiple Sclerosis and Related Disorders|January 3, 2020
To treat or not to treat: Sequential individualized treatment evaluation in relapsing multiple sclerosisGabriel Bsteh, Harald Hegen, Carolin Dosser, et al.
Journal of Central Nervous System Disease|April 4, 2022
Recovery of Chronic Inflammatory Demyelinating Polyneuropathy on Treatment With Ocrelizumab in a Patient With Co-Existing Multiple SclerosisMichael Auer, Harald Hegen, Anna Hotter, et al.
Plos One|June 12, 2020
Influence of physical activity on serum vitamin D levels in people with multiple sclerosisAngelika Bauer, Ivan Lechner, Michael Auer, et al.
European Journal of Neurology|October 19, 2020
Cerebrospinal fluid protein in Guillain-Barré syndrome: Need for age-dependent interpretationHarald Hegen, Felix Ladstätter, Gabriel Bsteh, et al.
Multiple Sclerosis and Related Disorders|April 27, 2022
Alemtuzumab induced hemodynamic change in relapsing multiple sclerosis occurs independent of corticosteroid premedication - a retrospective multicentre studyFranziska Di Pauli, Katharina Riedl, Harald Hegen, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|September 14, 2020
Inner nuclear layer and olfactory threshold are interlinked and reflect inflammatory activity in multiple sclerosisGabriel Bsteh, Harald Hegen, Patrick Altmann, et al.
Pageof 5